Abonnement for 2 €

Sikre fra 2 euro

Financial Data API

Terminal Financial Data API

Affimed Aktie News & Pressemeldungen

Affimed Eulerpool Nyheter

FDA stärkt Hoffnung für Patient:innen mit fortgeschrittener Lymphomtherapie

1

1

Affimed Aksje Nyheter

Affimed blir fulgt av mange journalister og investorer over hele verden. De nyeste Affimed nyhetene presenterer vi her.

·
Yahoo
Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)
·
Yahoo
Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer
·
Yahoo
Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients
·
Yahoo
FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy
·
Yahoo
Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)
·
Yahoo
Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ...
·
SeekingAlpha
Affimed N.V. (AFMD) Q3 2024 Earnings Call Transcript
·
Yahoo
Affimed N.V.: Q3 Earnings Snapshot
·
Yahoo
Affimed Reports Third Quarter 2024 Financial Results & Business Update
·
SeekingAlpha
Affimed N.V. 2024 Q3 - Results - Earnings Call Presentation

1

2

1

2

Affimed Aksje Pressemeldinger

Affimed publiserer regelmessig meldinger som er relevante for investorer på selskapets nettside.

Gjør de beste investeringene i ditt liv

Sikre deg fra 2 euro